CORONÉO, a Montreal-based medical device company, develops instruments and enabling technologies that render cardiac surgery less invasive and more cost-effective. Working closely with leading Canadian and international surgeons during all stages of product development – from problem statement to concept design to product validation – CORONÉO has been able to quickly respond to the “real needs” of the healthcare industry.

Possessing its own prototype facilities, plastic injection, and clean room capabilities, CORONÉO can expediently introduce prototypes and rapidly converge design iterations during market sensitive product development. The company is certified to ISO 13485:2003.

Cor-Valv Aortic Retractor

Since its inception in 1998, the company’s ongoing developments have led to the successful marketing of six surgical platforms, and differentiated CORONÉO as a responsive and noteworthy provider of novel surgical solutions. The company’s four reusable titanium and two single-use plastic products feature patented or patent-pending innovations, and allow adult or pediatric interventions through either sternotomy or intercostal approaches. All products have received FDA and CE mark approval, and are currently commercialized in thirteen countries.

Cor-Valv Mitral Retractor

In recent years, CORONÉO has undertaken to grow its business in the field of implantable devices by leveraging its established infrastructure and competence network. The company’s first implantable device, the Extra-Aortic Ring, is a unique annuloplasty device allowing surgeons to repair a dilated aortic root by restoring valve leaflet contact. The expansible nature of the aortic ring permits not only the physiology of the aortic root to be preserved, but more importantly, by sparing the patient’s valve leaflets it avoids entire valve replacement with a prosthetic mechanical valve. No such device presently exists on the market.